HCA Healthcare Company Profile (NYSE:HCA)

About HCA Healthcare (NYSE:HCA)

HCA Healthcare logoHCA Healthcare, Inc., formerly HCA Holdings, Inc., is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia. As of December 31, 2016, the American Group included 80 hospitals, which were located in Colorado, northern Georgia, Kansas, southern Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas. As of December 31, 2016, the Company operated six hospitals in England. The Company owns, manages or operates hospitals, freestanding surgery centers and freestanding emergency care facilities, walk-in clinics, diagnostic and imaging centers, among others.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Healthcare Facilities & Services
  • Sub-Industry: Health Care Facilities
  • Symbol: NYSE:HCA
  • CUSIP: 40412C10
  • Web: hcahealthcare.com
  • Market Cap: $29.28 billion
  • Outstanding Shares: 361,250,000
Average Prices:
  • 50 Day Moving Avg: $77.65
  • 200 Day Moving Avg: $81.88
  • 52 Week Range: $67.00 - $91.03
  • Trailing P/E Ratio: 10.86
  • Foreward P/E Ratio: 10.64
  • P/E Growth: 1.13
Sales & Book Value:
  • Annual Revenue: $42.27 billion
  • Price / Sales: 0.69
  • Book Value: ($18.72) per share
  • Price / Book: -4.33
  • EBITDA: $8.2 billion
  • Net Margins: 7.41%
  • Return on Assets: 9.33%
  • Debt-to-Equity Ratio: -6.19%
  • Current Ratio: 1.62%
  • Quick Ratio: 1.35%
  • Average Volume: 2.44 million shs.
  • Beta: 0.62
  • Short Ratio: 7.27

Frequently Asked Questions for HCA Healthcare (NYSE:HCA)

What is HCA Healthcare's stock symbol?

HCA Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCA."

How were HCA Healthcare's earnings last quarter?

HCA Healthcare Inc (NYSE:HCA) issued its quarterly earnings data on Tuesday, July, 25th. The company reported $1.75 EPS for the quarter, missing the consensus estimate of $1.80 by $0.05. The firm earned $10.73 billion during the quarter, compared to analysts' expectations of $10.76 billion. The company's revenue was up 4.0% on a year-over-year basis. During the same period in the previous year, the company posted $1.66 EPS. View HCA Healthcare's Earnings History.

When will HCA Healthcare make its next earnings announcement?

HCA Healthcare is scheduled to release their next quarterly earnings announcement on Tuesday, October, 31st 2017. View Earnings Estimates for HCA Healthcare.

What guidance has HCA Healthcare issued on next quarter's earnings?

HCA Healthcare issued an update on its FY17 earnings guidance on Tuesday, July, 25th. The company provided earnings per share guidance of $7.00-7.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.35. The company issued revenue guidance of $43.0-44.0 billion, compared to the consensus revenue estimate of $43.37 billion.

Where is HCA Healthcare's stock going? Where will HCA Healthcare's stock price be in 2017?

21 brokers have issued 12 month price targets for HCA Healthcare's stock. Their forecasts range from $85.00 to $103.00. On average, they anticipate HCA Healthcare's stock price to reach $90.95 in the next year. View Analyst Ratings for HCA Healthcare.

What are analysts saying about HCA Healthcare stock?

Here are some recent quotes from research analysts about HCA Healthcare stock:

  • 1. According to Zacks Investment Research, "HCA Healthcare’s shares have lost value in six months' time. The company continues to suffer from weak commercial business that has faced declining volumes of admissions over the last four to five quarters. Its high bad debts and disappointing international business are the other headwinds. The company has also trimmed its 2017 guidance which bothers us. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 2% downward over the last 60 days. Its top-line has been growing over the past several quarters on strong volumes and improved payor and service mix. A number of acquisitions made over the past many years have helped the company gain a strong foothold in the industry. " (10/17/2017)
  • 2. Cantor Fitzgerald analysts commented, "CMS proposed a better than expected FY 18 hospital inpatient (IPPS) rate increase of 1.6% for operating payments and a total increase of 2.9%, including a new reimbursement methodology for uncompensated care. Although the impact of the new rates will vary among hospitals depending on patient mix and the level of uncompensated care, we expect better rates will help hospital stocks, which have been hurt by concern for the ACA. The proposed hospital IPPS rates were significantly higher than our 1% estimate (vs. 0.8%-2.3% over past five years)." (4/17/2017)

Who are some of HCA Healthcare's key competitors?

Who are HCA Healthcare's key executives?

HCA Healthcare's management team includes the folowing people:

  • R. Milton Johnson, Chairman of the Board, Chief Executive Officer
  • Samuel N. Hazen, President, Chief Operating Officer
  • William B. Rutherford, Chief Financial Officer, Executive Vice President
  • Michael S. Cuffe M.D., President — Physician Services Group
  • Jon Mark Foster, President - American Group
  • Charles J. Hall, President - National Group
  • Arnold Bruce Moore Jr., President - Service Line and Operations Integration
  • Jonathan B. Perlin M.D., President - Clinical Services Group, Chief Medical Officer
  • J. William B. Morrow, Senior Vice President - Finance, Treasurer
  • Paul Martin Paslick, Senior Vice President, Chief Information Officer

Who owns HCA Healthcare stock?

HCA Healthcare's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include APG Asset Management N.V. (0.95%), Assenagon Asset Management S.A. (0.44%), State Treasurer State of Michigan (0.02%), Shell Asset Management Co. (0.01%), Mutual of America Capital Management LLC (0.01%) and Meeder Asset Management Inc. (0.01%). Company insiders that own HCA Healthcare stock include A Bruce Moore Jr, Alan R Yuspeh, Charles J Hall, Charles O Holliday Jr, Christopher F Wyatt, David Gwin Anderson, Henry R Kravis, Jana Joustra Davis, Jane D Englebright, John M Steele, Jonathan B Perlin, Joseph N Steakley, Juan Vallarino, Michael S Cuffe, P Martin Paslick, Ravi S Chari, Robert A Waterman, Sandra L Morgan, Thomas F Frist Jr and Victor L Campbell. View Institutional Ownership Trends for HCA Healthcare.

Who sold HCA Healthcare stock? Who is selling HCA Healthcare stock?

HCA Healthcare's stock was sold by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc., Shell Asset Management Co., State Treasurer State of Michigan, Robeco Institutional Asset Management B.V. and Eqis Capital Management Inc.. Company insiders that have sold HCA Healthcare stock in the last year include A Bruce Moore Jr, Charles J Hall, Christopher F Wyatt, Jana Joustra Davis, Jane D Englebright, John M Steele, Jonathan B Perlin, Michael S Cuffe, P Martin Paslick, Ravi S Chari, Robert A Waterman and Sandra L Morgan. View Insider Buying and Selling for HCA Healthcare.

Who bought HCA Healthcare stock? Who is buying HCA Healthcare stock?

HCA Healthcare's stock was purchased by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Assenagon Asset Management S.A. and Mutual of America Capital Management LLC. Company insiders that have bought HCA Healthcare stock in the last two years include Charles O Holliday Jr and Thomas F Frist Jr. View Insider Buying and Selling for HCA Healthcare.

How do I buy HCA Healthcare stock?

Shares of HCA Healthcare can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is HCA Healthcare's stock price today?

One share of HCA Healthcare stock can currently be purchased for approximately $81.05.

MarketBeat Community Rating for HCA Healthcare (NYSE HCA)
Community Ranking:  3.6 out of 5 (star star star)
Outperform Votes:  714 (Vote Outperform)
Underperform Votes:  267 (Vote Underperform)
Total Votes:  981
MarketBeat's community ratings are surveys of what our community members think about HCA Healthcare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for HCA Healthcare (NYSE:HCA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 5 Hold Ratings, 16 Buy Ratings
Consensus Rating:Buy (Score: 2.76)
Consensus Price Target: $90.95 (12.21% upside)
Consensus Price Target History for HCA Healthcare (NYSE:HCA)
Price Target History for HCA Healthcare (NYSE:HCA)
Analysts' Ratings History for HCA Healthcare (NYSE:HCA)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/20/2017MizuhoReiterated RatingBuyN/AView Rating Details
10/19/2017Robert W. BairdSet Price TargetBuy$93.00 -> $86.00N/AView Rating Details
10/19/2017Oppenheimer Holdings, Inc.Reiterated RatingBuy$95.00 -> $90.00N/AView Rating Details
10/19/2017Bank of America CorporationLower Price TargetNeutral$92.00 -> $86.00N/AView Rating Details
10/19/2017Royal Bank Of CanadaReiterated RatingOutperform$90.00N/AView Rating Details
10/19/2017KeyCorpReiterated RatingOverweight$95.00 -> $90.00N/AView Rating Details
10/19/2017Jefferies Group LLCReiterated RatingBuy$90.00N/AView Rating Details
10/18/2017Raymond James Financial, Inc.DowngradeStrong-Buy -> Market PerformN/AView Rating Details
10/16/2017BMO Capital MarketsInitiated CoverageOutperform$90.00N/AView Rating Details
10/15/2017SunTrust Banks, Inc.Set Price TargetBuy$90.00N/AView Rating Details
10/13/2017Cantor FitzgeraldReiterated RatingBuy$95.00N/AView Rating Details
10/4/2017Piper Jaffray CompaniesReiterated RatingBuy$92.00HighView Rating Details
8/17/2017Morgan StanleyLower Price TargetEqual Weight$88.00 -> $85.00LowView Rating Details
8/14/2017ArgusLower Price TargetBuy$100.00 -> $93.00LowView Rating Details
7/26/2017Citigroup Inc.Lower Price TargetNeutral$89.00 -> $87.00MediumView Rating Details
6/6/2017Leerink SwannUpgradeMarket Perform -> Outperform$92.00 -> $100.00LowView Rating Details
4/4/2017Deutsche Bank AGInitiated CoverageBuy$103.00LowView Rating Details
1/31/2017Evercore ISIBoost Price TargetBuy$88.00N/AView Rating Details
1/17/2017Avondale PartnersUpgradeMarket Perform -> Outperform$96.00N/AView Rating Details
11/15/2016Sanford C. BernsteinReiterated RatingMarket Perform$89.00 -> $85.00N/AView Rating Details
10/25/2016Wolfe ResearchInitiated CoverageOutperformN/AView Rating Details
7/29/2016Credit Suisse GroupReiterated RatingBuy$87.00N/AView Rating Details
7/29/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$85.00N/AView Rating Details
6/1/2016Longbow ResearchDowngradeOutperform -> Market Perform$74.00N/AView Rating Details
6/1/2016Barclays PLCLower Price TargetOverweight$80.00 -> $79.00N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
5/4/2016WedbushReiterated RatingOutperform$88.00 -> $90.00N/AView Rating Details
1/4/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
12/17/2015Goldman Sachs Group, Inc. (The)DowngradeBuy -> Neutral$80.00N/AView Rating Details
(Data available from 10/22/2015 forward)


Earnings History for HCA Healthcare (NYSE:HCA)
Earnings by Quarter for HCA Healthcare (NYSE:HCA)
Earnings History by Quarter for HCA Healthcare (NYSE HCA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2017$1.57N/AView Earnings Details
7/25/2017Q2 2017$1.80$1.75$10.76 billion$10.73 billionViewN/AView Earnings Details
5/2/2017Q1 2017$1.74$1.74$10.64 billion$10.62 billionViewListenView Earnings Details
1/31/2017Q416$1.78$1.89$10.67 billion$10.64 billionViewN/AView Earnings Details
10/27/2016Q316$1.42$1.61$10.41 billion$10.27 billionViewListenView Earnings Details
7/28/2016Q216$1.56$1.66$10.49 billion$10.32 billionViewListenView Earnings Details
5/3/2016Q116$1.49$1.71$10.24 billion$10.26 billionViewN/AView Earnings Details
1/28/2016Q415$1.40$1.69$10.16 billion$10.25 billionViewListenView Earnings Details
10/27/2015Q315$1.19$1.17$9.90 billion$9.86 billionViewListenView Earnings Details
8/5/2015Q215$1.34$1.37$9.82 billion$9.90 billionViewN/AView Earnings Details
5/5/2015Q115$1.34$1.35$9.56 billion$9.68 billionViewN/AView Earnings Details
2/3/2015Q414$1.25$1.33$9.59 billion$9.64 billionViewN/AView Earnings Details
10/28/2014Q314$1.05$1.16$9.12 billion$9.22 billionViewN/AView Earnings Details
7/29/2014Q214$1.37$1.37$8.98 billion$9.96 billionViewN/AView Earnings Details
4/29/2014Q114$0.85$0.84$8.90 billion$9.68 billionViewN/AView Earnings Details
2/4/2014Q114$0.86$0.92$8.82 billion$8.43 billionViewN/AView Earnings Details
11/5/2013Q313$0.74$0.79$8.40 billion$9.41 billionViewN/AView Earnings Details
8/1/2013Q2 2013$0.83$0.91$8.44 billion$8.45 billionViewListenView Earnings Details
5/2/2013Q1 2013$0.82$0.79$9.38 billion$8.44 billionViewN/AView Earnings Details
2/5/2013Q4 2012$0.83$0.92$8.95 billion$8.43 billionViewN/AView Earnings Details
11/1/2012Q312$0.90$0.78$8.04 billion$8.06 billionViewN/AView Earnings Details
8/6/2012$0.78$0.85ViewN/AView Earnings Details
5/3/2012$0.99$1.18ViewN/AView Earnings Details
2/6/2012$0.76$0.94ViewN/AView Earnings Details
11/1/2011$0.43$0.60ViewN/AView Earnings Details
7/25/2011$0.59$0.55ViewN/AView Earnings Details
5/4/2011$0.75$0.85ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for HCA Healthcare (NYSE:HCA)
2017 EPS Consensus Estimate: $7.10
2018 EPS Consensus Estimate: $7.60
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20176$1.66$1.82$1.77
Q2 20176$1.78$1.86$1.82
Q3 20176$1.48$1.69$1.59
Q4 20176$1.80$2.09$1.93
Q1 20182$1.72$1.81$1.77
Q2 20182$1.81$1.95$1.88
Q3 20182$1.68$1.92$1.80
Q4 20182$2.03$2.28$2.16
Q1 20191$2.05$2.05$2.05
Q2 20191$2.19$2.19$2.19
(Data provided by Zacks Investment Research)


Current Dividend Information for HCA Healthcare (NYSE:HCA)
Most Recent Dividend:12/21/2012
Dividend Yield:0.00%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:0.00% (Trailing 12 Months of Earnings)
0.00% (Based on This Year's Estimates)
0.00% (Based on Next Year's Estimates)
Dividend Payments by Quarter for HCA Healthcare (NYSE:HCA)

Dividend History by Quarter for HCA Healthcare (NYSE HCA)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for HCA Healthcare (NYSE:HCA)
Insider Ownership Percentage: 2.90%
Institutional Ownership Percentage: 73.76%
Insider Trades by Quarter for HCA Healthcare (NYSE:HCA)
Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)
Insider Trades by Quarter for HCA Healthcare (NYSE:HCA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/17/2017Michael S CuffeInsiderSell2,150$78.00$167,700.00View SEC Filing  
9/15/2017Michael S. CuffeInsiderSell2,150$79.87$171,720.50View SEC Filing  
8/15/2017Michael S CuffeInsiderSell2,150$79.88$171,742.00View SEC Filing  
7/17/2017Michael S CuffeInsiderSell2,150$86.44$185,846.00View SEC Filing  
6/22/2017Jonathan B. PerlinInsiderSell71,063$86.00$6,111,418.00View SEC Filing  
6/15/2017Michael S. CuffeInsiderSell2,150$84.86$182,449.00View SEC Filing  
5/23/2017Jana Joustra DavisSVPSell54,689$82.35$4,503,639.15View SEC Filing  
5/17/2017Sandra L MorganSVPSell5,915$82.74$489,407.10View SEC Filing  
5/15/2017Michael S CuffeInsiderSell2,150$84.52$181,718.00View SEC Filing  
5/11/2017Jana Joustra DavisSVPSell8,302$85.02$705,836.04View SEC Filing  
5/10/2017Jane D EnglebrightSVPSell5,005$85.31$426,976.55View SEC Filing  
5/5/2017Robert A WatermanSVPSell246,000$83.12$20,447,520.00View SEC Filing  
5/5/2017Thomas F Frist JrMajor ShareholderBuy361,205$83.06$30,001,687.30View SEC Filing  
4/17/2017Michael S CuffeInsiderSell2,150$85.00$182,750.00View SEC Filing  
3/27/2017Ravi S ChariSVPSell31,956$90.00$2,876,040.00View SEC Filing  
2/7/2017John M SteeleSVPSell31,535$82.55$2,603,214.25View SEC Filing  
2/3/2017Charles J HallInsiderSell100,000$83.79$8,379,000.00View SEC Filing  
2/3/2017Jana Joustra DavisSVPSell7,903$82.49$651,918.47View SEC Filing  
2/2/2017Charles J HallInsiderSell100,000$82.38$8,238,000.00View SEC Filing  
1/17/2017Michael S CuffeInsiderSell2,150$80.00$172,000.00View SEC Filing  
1/9/2017Michael S. CuffeInsiderSell4,300$78.00$335,400.00View SEC Filing  
11/9/2016A Bruce Moore JrInsiderSell167,967$73.65$12,370,769.55View SEC Filing  
11/8/2016Sandra L MorganSVPSell18,556$76.84$1,425,843.04View SEC Filing  
11/7/2016Christopher F WyattSVPSell3,152$79.00$249,008.00View SEC Filing  
10/28/2016Michael S. CuffeInsiderSell2,150$79.41$170,731.50View SEC Filing  
10/28/2016P. Martin PaslickSVPSell36,004$78.79$2,836,755.16View SEC Filing  
5/24/2016Alan R YuspehSVPSell15,000$77.82$1,167,300.00View SEC Filing  
5/24/2016Michael S CuffeInsiderSell2,575$76.20$196,215.00View SEC Filing  
5/20/2016Joseph N SteakleySVPSell16,327$77.07$1,258,321.89View SEC Filing  
5/10/2016Henry R KravisMajor ShareholderSell9,360,958$80.12$749,999,954.96View SEC Filing  
5/9/2016Juan VallarinoSVPSell13,501$81.27$1,097,226.27View SEC Filing  
5/6/2016Charles J HallInsiderSell100,023$80.99$8,100,862.77View SEC Filing  
5/6/2016Joseph N SteakleySVPSell60,004$80.82$4,849,523.28View SEC Filing  
5/5/2016Jana Joustra DavisSVPSell11,970$80.02$957,839.40View SEC Filing  
5/4/2016Charles O Holliday JrDirectorBuy4,000$79.68$318,720.00View SEC Filing  
5/4/2016P. Martin PaslickSVPSell18,000$79.46$1,430,280.00View SEC Filing  
4/28/2016John M SteeleSVPSell40,004$82.56$3,302,730.24View SEC Filing  
4/28/2016Jonathan B PerlinCMOSell30,000$82.00$2,460,000.00View SEC Filing  
4/25/2016Michael S CuffeInsiderSell2,575$80.73$207,879.75View SEC Filing  
4/18/2016John M SteeleSVPSell19,464$81.00$1,576,584.00View SEC Filing  
4/14/2016John M SteeleSVPSell3,036$81.00$245,916.00View SEC Filing  
3/24/2016Michael S CuffeInsiderSell2,575$76.19$196,189.25View SEC Filing  
3/23/2016John M SteeleSVPSell22,500$78.00$1,755,000.00View SEC Filing  
2/24/2016Michael S CuffeInsiderSell2,575$70.00$180,250.00View SEC Filing  
2/19/2016Jana Joustra DavisSVPSell36,159$67.17$2,428,800.03View SEC Filing  
2/17/2016Jane D. EnglebrightSVPSell4,436$67.08$297,566.88View SEC Filing  
2/1/2016David Gwin AndersonSVPSell35,013$70.52$2,469,116.76View SEC Filing  
1/29/2016Victor L. CampbellSVPSell165,016$68.86$11,363,001.76View SEC Filing  
1/28/2016Michael S. CuffeinsiderSell5,150$70.00$360,500.00View SEC Filing  
12/1/2015Michael S. CuffeinsiderSell2,575$70.00$180,250.00View SEC Filing  
10/26/2015Michael S. CuffeinsiderSell2,575$70.00$180,250.00View SEC Filing  
9/24/2015Michael S. CuffeinsiderSell2,575$83.42$214,806.50View SEC Filing  
8/25/2015Juan VallarinoSVPSell27,002$85.76$2,315,691.52View SEC Filing  
8/24/2015Michael S. CuffeinsiderSell2,575$82.32$211,974.00View SEC Filing  
8/17/2015Donald W StinnettSVPSell67,506$91.25$6,159,922.50View SEC Filing  
8/14/2015Alan R YuspehSVPSell14,000$91.24$1,277,360.00View SEC Filing  
8/13/2015Juan VallarinoSVPSell11,036$90.89$1,003,062.04View SEC Filing  
6/25/2015Jonathan B PerlinCMOSell32,010$87.31$2,794,793.10View SEC Filing  
6/11/2015R Milton JohnsonCEOSell140,642$83.89$11,798,457.38View SEC Filing  
5/22/2015Donald W StinnettSVPSell22,502$82.39$1,853,939.78View SEC Filing  
5/20/2015Jana Joustra DavisSVPSell3,302$82.74$273,207.48View SEC Filing  
5/19/2015Jon M FosterInsiderSell36,000$81.00$2,916,000.00View SEC Filing  
5/19/2015Jonathan B PerlinCMOSell18,000$83.00$1,494,000.00View SEC Filing  
5/18/2015A Bruce Moore JrInsiderSell100,000$80.83$8,083,000.00View SEC Filing  
5/18/2015David Gwin AndersonSVPSell30,000$80.67$2,420,100.00View SEC Filing  
5/18/2015Jonathan B PerlinCMOSell18,000$81.00$1,458,000.00View SEC Filing  
5/18/2015R Milton JohnsonCEOSell140,642$79.89$11,235,889.38View SEC Filing  
5/7/2015Charles J HallInsiderSell252,026$74.54$18,786,018.04View SEC Filing  
4/15/2015Samuel N HazenCOOSell180,000$80.00$14,400,000.00View SEC Filing  
2/23/2015Charles J HallInsiderSell50,000$70.10$3,505,000.00View SEC Filing  
2/12/2015Jane D EnglebrightSVPSell10,774$69.06$744,052.44View SEC Filing  
1/12/2015Donald W StinnettSVPSell2,521$76.00$191,596.00View SEC Filing  
12/23/2014John M SteeleSVPSell14,000$75.00$1,050,000.00View SEC Filing  
12/23/2014Jonathan B PerlinCMOSell10,000$75.00$750,000.00View SEC Filing  
12/23/2014Samuel N HazenInsiderSell180,051$75.00$13,503,825.00View SEC Filing  
11/3/2014John M SteeleSVPSell13,000$72.00$936,000.00View SEC Filing  
11/3/2014Jonathan B PerlinCMOSell10,000$72.00$720,000.00View SEC Filing  
8/4/2014Samuel N HazenInsiderSell19,374$66.00$1,278,684.00View SEC Filing  
7/30/2014David Gwin AndersonSVPSell22,524$66.53$1,498,521.72View SEC Filing  
7/16/2014Juan VallarinoSVPSell15,000$60.00$900,000.00View SEC Filing  
6/20/2014Juan VallarinoSVPSell15,000$57.50$862,500.00View SEC Filing  
6/5/2014Jonathan B PerlinCMOSell20,000$55.00$1,100,000.00View SEC Filing  
5/6/2014Wayne Joseph RileyDirectorSell10,000$52.00$520,000.00View SEC Filing  
5/5/2014David Gwin AndersonSVPSell42,007$52.22$2,193,605.54View SEC Filing  
5/2/2014A Bruce Moore, Jr.InsiderSell75,174$52.53$3,948,890.22View SEC Filing  
5/1/2014Juan VallarinoSVPSell15,000$52.50$787,500.00View SEC Filing  
4/30/2014John RoweDirectorBuy14,356$52.24$749,957.44View SEC Filing  
2/19/2014Charles HallInsiderSell185,596$49.92$9,264,952.32View SEC Filing  
2/7/2014Samuel HazenInsiderSell29,016$48.00$1,392,768.00View SEC Filing  
11/26/2013Juan VallarinoSVPSell22,042$45.00$991,890.00View SEC Filing  
9/18/2013Donald StinnettSVPSell12,500$42.00$525,000.00View SEC Filing  
8/20/2013John SteeleSVPSell33,189$38.63$1,282,091.07View SEC Filing  
8/14/2013Juan VallarinoSVPSell50,142$39.49$1,980,107.58View SEC Filing  
5/17/2013Jon M FosterInsiderSell15,955$39.04$622,883.20View SEC Filing  
8/8/2012Of America Corp /De/ BankMajor ShareholderSell145,491$26.91$3,915,162.81View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for HCA Healthcare (NYSE:HCA)
Latest Headlines for HCA Healthcare (NYSE:HCA)
Loading headlines, please wait.



HCA Healthcare (HCA) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.